November 09, 2017 at 10:58PM Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products; Guidance for Industry

via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/2iKsCg3